Related Experiment Videos
Pathophysiology of chronic urticaria.
1Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
International Archives of Allergy and Immunology
|March 15, 2002
Summary
Chronic urticaria is often caused by histamine-releasing autoantibodies. These autoantibodies, particularly against Fc epsilon R1, trigger complement activation and are key to understanding this skin condition.
Area of Science:
- Immunodermatology
- Autoimmunity
- Allergy
Background:
- Chronic urticaria presents diverse pathophysiologies impacting diagnosis and treatment.
- Chronic 'idiopathic' urticaria poses a significant challenge, historically under-researched.
- Emerging evidence identifies autoantibodies as a major factor in chronic urticaria.
Purpose of the Study:
- To elucidate the role of autoantibodies in chronic urticaria.
- To investigate the specific targets and mechanisms of autoantibodies in chronic urticaria.
- To explore potential triggers for autoantibody development in susceptible individuals.
Main Methods:
- Analysis of patient sera for autoantibodies against Fc epsilon R1 and IgE.
- Assessment of autoantibody functionality (histamine release).
- Investigation of complement activation pathways in relation to autoantibodies.
Main Results:
- At least 30% of chronic urticaria patients have histamine-releasing autoantibodies (anti-Fc epsilon R1 or anti-IgE).
- Complement activation is implicated in the majority of these cases.
- Non-histamine-releasing anti-Fc epsilon R1 autoantibodies are found in other conditions, suggesting specificity.
Conclusions:
- Autoantibodies are causative agents in a significant subset of chronic urticaria.
- Complement activation is a key downstream mechanism.
- Genetic predisposition and molecular mimicry (e.g., Helicobacter pylori) are potential factors in autoantibody development.